4//SEC Filing
Yolles Robert A. 4
Accession 0001209191-09-046457
CIK 0001302554other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 5:35 PM ET
Size
6.9 KB
Accession
0001209191-09-046457
Insider Transaction Report
Form 4
Yolles Robert A.
Director
Transactions
- Award
Common Stock Options
2009-09-25+30,000→ 30,000 totalExercise: $1.36Exp: 2019-09-25→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]Such options vest in five equal annual installments, commencing 09/25/2010.
- [F2]Reported amount excludes: (i) options to purchase 33,096 shares of the Company's common stock, initially exercisable on 09/09/2003 and expiring on 09/09/2012, at an exercise price of $0.33; (ii) options to purchase 16,548 shares of the Company's common stock, initially exercisable on 09/09/2004 and expiring on 09/09/2013, at an exercise price of $0.33; (iii) options to purchase 33,096 shares of the Company's common stock, initially exercisable on 09/09/2005 and expiring on 09/09/2014, at an exercise price of $0.34; (iv) options to purchase 99,287 shares of the Company's common stock, initially exercisable on 02/18/2006 and expiring on 02/18/2015, at an exercise price of $0.34;
- [F3](v) options to purchase 33,096 shares of the Company's common stock, initially exercisable on 09/09/2006 and expiring on 09/09/2015, at an exercise price of $0.34; (vi) options to purchase 33,096 shares of the Company's common stock, initially exercisable on 09/09/2007 and expiring on 09/09/2016, at an exercise price of $0.34; and (vii) options to purchase 33,096 shares of the Company's common stock, initially exercisable on 09/09/2008 and expiring on 09/09/2017, at an exercise price of $0.34.
Documents
Issuer
Winston Pharmaceuticals, Inc.
CIK 0001302554
Entity typeother
Related Parties
1- filerCIK 0001447153
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 5:35 PM ET
- Size
- 6.9 KB